Multicenter phase II study of rituximab and temozolomide in recurrent primary central nervous system lymphoma

We initiated a prospective multicenter phase II trial using rituximab and temozolomide in immunocompetent patients with progressive or recurrent primary central nervous system lymphoma (PCNSL) based on activity observed in retrospective studies. Treatment consisted of an induction phase with rituxim...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Leuk Lymphoma
Main Authors: Nayak, Lakshmi, Abrey, Lauren E., Drappatz, Jan, Gilbert, Mark R., Reardon, David A., Wen, Patrick Y., Prados, Michael, Deangelis, Lisa M., Omuro, Antonio
Formato: Artigo
Idioma:Inglês
Publicado em: 2012
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4802006/
https://ncbi.nlm.nih.gov/pubmed/22656234
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/10428194.2012.698736
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados